Jurgen R Piet1, Afshin Zariri2, Floris Fransen2, Kim Schipper3, Peter van der Ley4, Diederik van de Beek5, Arie van der Ende6. 1. Department of Neurology, Center of Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Amsterdam, PO Box 22660, The Netherlands; Department of Medical Microbiology, Center of Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Amsterdam, PO Box 22660, The Netherlands. 2. Institute for Translational Vaccinology (InTraVacc), Antonie van Leeuwenhoeklaan 9, 3720 AL Bilthoven, The Netherlands; Department of Infectious Diseases and Immunology, Utrecht University, 3584 CL Utrecht, The Netherlands. 3. Department of Medical Microbiology, Center of Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Amsterdam, PO Box 22660, The Netherlands. 4. Institute for Translational Vaccinology (InTraVacc), Antonie van Leeuwenhoeklaan 9, 3720 AL Bilthoven, The Netherlands. 5. Department of Neurology, Center of Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Amsterdam, PO Box 22660, The Netherlands. 6. Department of Medical Microbiology, Center of Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Amsterdam, PO Box 22660, The Netherlands; The Netherlands Reference Laboratory for Bacterial Meningitis, Academic Medical Center, Amsterdam, PO Box 22660, The Netherlands. Electronic address: A.vanderende@amc.uva.nl.
Abstract
OBJECTIVE: Lipopolysaccharide (LPS) is a major component of the Neisseria meningitidis outer membrane. Here we report a patient with meningococcal meningitis of which the causative isolate lacked LPS. Thus far, no naturally occurring LPS-deficient meningococcal isolate has been known to cause clinical disease. METHODS: We used SDS-PAGE, silver staining and LPS-specific antibodies in whole cell ELISA to determine LPS presence in the causative isolate. Meningococcal whole genome sequencing was performed using Roche 454-sequencing. The N. meningitidis strain MC58 was used to compare all LPS biosynthesis associated genes. We compared growth characteristics of Escherichia coli transformed with a plasmid containing 2 lpxH types. RESULTS: The patient presented with isolated thunderclap headache. Analysis of the causative N. meningitidis showed no LPS. Whole genome sequencing revealed a mutation located in lpxH explaining LPS-deficiency. Expression of this lpxH variant in E. coli resulted in growth impairment compared to E. coli expressing the meningococcal wild type lpxH variant. In addition, inactivating lpxH in N. meningitidis H44/76 by insertional inactivation with a kanamycin cassette resulted in a LPS-deficient phenotype. CONCLUSIONS: We describe invasive meningococcal disease caused by a naturally occurring LPS-deficient meningococcal isolate.
OBJECTIVE:Lipopolysaccharide (LPS) is a major component of the Neisseria meningitidis outer membrane. Here we report a patient with meningococcal meningitis of which the causative isolate lacked LPS. Thus far, no naturally occurring LPS-deficient meningococcal isolate has been known to cause clinical disease. METHODS: We used SDS-PAGE, silver staining and LPS-specific antibodies in whole cell ELISA to determine LPS presence in the causative isolate. Meningococcal whole genome sequencing was performed using Roche 454-sequencing. The N. meningitidis strain MC58 was used to compare all LPS biosynthesis associated genes. We compared growth characteristics of Escherichia coli transformed with a plasmid containing 2 lpxH types. RESULTS: The patient presented with isolated thunderclap headache. Analysis of the causative N. meningitidis showed no LPS. Whole genome sequencing revealed a mutation located in lpxH explaining LPS-deficiency. Expression of this lpxH variant in E. coli resulted in growth impairment compared to E. coli expressing the meningococcal wild type lpxH variant. In addition, inactivating lpxH in N. meningitidis H44/76 by insertional inactivation with a kanamycin cassette resulted in a LPS-deficient phenotype. CONCLUSIONS: We describe invasive meningococcal disease caused by a naturally occurring LPS-deficient meningococcal isolate.
Authors: Dorothea M C Hill; Jay Lucidarme; Stephen J Gray; Lynne S Newbold; Roisin Ure; Carina Brehony; Odile B Harrison; James E Bray; Keith A Jolley; Holly B Bratcher; Julian Parkhill; Christoph M Tang; Ray Borrow; Martin C J Maiden Journal: Lancet Infect Dis Date: 2015-10-27 Impact factor: 25.071
Authors: Jun-Rong Wei; Daryl L Richie; Mina Mostafavi; Louis E Metzger; Christopher M Rath; William S Sawyer; Kenneth T Takeoka; Charles R Dean Journal: mSphere Date: 2017-07-26 Impact factor: 4.389
Authors: Elizaveta B Boitsova; Andrey V Morgun; Elena D Osipova; Elena A Pozhilenkova; Galina P Martinova; Olga V Frolova; Raissa Ya Olovannikova; Abolghasem Tohidpour; Yana V Gorina; Yulia A Panina; Alla B Salmina Journal: J Neuroinflammation Date: 2018-07-04 Impact factor: 8.322
Authors: Daryl L Richie; Kenneth T Takeoka; Jade Bojkovic; Louis E Metzger; Christopher M Rath; William S Sawyer; Jun-Rong Wei; Charles R Dean Journal: PLoS One Date: 2016-08-15 Impact factor: 3.240